You must be 21 years old or 18 years old with a medical card to access this website.
Are you eligible?
You're not old enough to visit Weevader. Please come back when you're 21.
Beyond THC and CBD, the cannabis plant produces over 100 other cannabinoids — collectively known as minor cannabinoids. These compounds are gaining significant attention as researchers discover their unique therapeutic properties and as product manufacturers find ways to isolate and concentrate them. From CBN for sleep to THCV for energy, minor cannabinoids are expanding what cannabis can do.
CBN is formed when THC ages and oxidizes — it's literally old THC. While it was once considered a degradation byproduct, CBN has emerged as one of the most sought-after minor cannabinoids, primarily for its reputed sedative effects.
CBG is called the "mother cannabinoid" because its acidic form (CBGA) is the precursor from which all other cannabinoids are synthesized. Young cannabis plants contain high levels of CBGA, which enzymes convert into THCA, CBDA, and CBCA as the plant matures. By harvest, most CBG has been converted, leaving only 1% or less in the final flower.
THCV is one of the most intriguing minor cannabinoids. Structurally similar to THC but with a shorter carbon chain, THCV produces notably different effects and has earned the nickname "diet weed" and "the sports car of cannabinoids" for its energetic, clear-headed profile.
CBC is the third most abundant cannabinoid in many cannabis strains, though it remains far less studied than THC or CBD. It doesn't bind strongly to CB1 or CB2 receptors but interacts with other receptors involved in pain perception, including TRPV1 and TRPA1 (vanilloid receptors).
Delta-8 and delta-10 THC are isomers of the more common delta-9 THC. They share the same chemical formula but differ in the position of a double bond in the carbon chain. These subtle structural differences produce noticeably different effects.
Delta-8 produces a milder high than delta-9, often described as "THC lite." Users report less anxiety, less paranoia, and a clearer head. It's about 50-75% as potent as delta-9 THC. Delta-8 gained massive popularity through the hemp loophole, as it can be synthesized from CBD extracted from legal hemp. However, many states have moved to ban or regulate it.
Delta-10 is even milder than delta-8 and is associated with uplifting, sativa-like effects. Users describe it as energizing and focus-enhancing with minimal psychoactivity. Like delta-8, it's typically synthesized from hemp-derived CBD and faces increasing regulatory scrutiny.
HHC is a hydrogenated form of THC — similar to how margarine is hydrogenated vegetable oil. It produces psychoactive effects comparable to delta-9 THC but with reportedly greater stability and a longer shelf life. HHC exists naturally in cannabis in trace amounts but is commercially produced through hydrogenation of THC or CBD.
CBDV is a variant of CBD with a shorter carbon chain. Early research suggests it may be particularly effective for nausea, seizures, and autism spectrum disorder. GW Pharmaceuticals (makers of Epidiolex) has been studying CBDV for epilepsy treatment. Like CBD, CBDV is non-psychoactive.
Minor cannabinoid products are increasingly available at dispensaries and through delivery services. Here's how to find them: